Please login to the form below

Not currently logged in
Email:
Password:

Positive opinion for Allergan's NDO treatment

A positive opinion is given from the Irish Medicines Board for BOTOX treatment for neurogenic detrusor overactivity (NDO)

Allergan's BOTOX has received a positive opinion from the Irish Medicines Board, for the use of BOTOX for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO).

NDO results from neurogenic bladder, due to stable sub-cervical spinal cord injury (SCI) or multiple sclerosis (MS). NDO results in involuntary contractions of the detrusor muscle within the bladder during its filling stage. This over activity often leads to urinary incontinence.

It has been shown that targeted injections of BOTOX into the bladder muscle can reduce the involuntary contractions and increase bladder capacity, therefore reducing the number of urinary leaks.

Gaining this opinion is considered to be an important step towards securing national licences in the 14 European countries involved in the Mutual Recognition Procedure.

9th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics